HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$526M |
| 2 |
NVIDIA
NVDA
|
+$492M |
| 3 |
Apple
AAPL
|
+$315M |
| 4 |
Target
TGT
|
+$188M |
| 5 |
American Express
AXP
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$604M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$201M |
| 3 |
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
|
+$200M |
| 4 |
Tesla
TSLA
|
+$173M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.71% |
| 2 | Financials | 12.6% |
| 3 | Consumer Discretionary | 11.8% |
| 4 | Healthcare | 11.63% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
SiriusPoint
SPNT
$3.03B
| $124K | ﹤0.01% |
23,013
-2,317
| -9% | -$13.9K |
|
3002
GrafTech
EAF
$184M
| $122K | ﹤0.01% |
1,731
+8
| +0.5% | +$697 |
|
3003
Heron Therapeutics
HRTX
$93.4M
| $122K | ﹤0.01% |
44,407
+24,709
| +125% | +$99.2K |
|
3004
Ardagh Metal Packaging
AMBP
$2.96B
| $121K | ﹤0.01% |
19,870
-19,729
| -50% | -$133K |
|
|
DSL
3005
DoubleLine Income Solutions Fund
DSL
$1.22B
| $121K | ﹤0.01% |
10,000
| – | – |
|
|
FSR
3006
DELISTED
Fisker Inc.
FSR
| $120K | ﹤0.01% |
14,099
-10,742
| -43% | -$111K |
|
|
AERI
3007
DELISTED
Aerie Pharmaceuticals
AERI
| $120K | ﹤0.01% |
16,248
-1,097
| -6% | -$7.73K |
|
|
IS
3008
DELISTED
ironSource Ltd.
IS
| $119K | ﹤0.01% |
49,842
+30,053
| +152% | +$101K |
|
|
ESPR
3009
DELISTED
Esperion Therapeutics
ESPR
| $118K | ﹤0.01% |
18,726
-3,190
| -15% | -$18.1K |
|
3010
Iovance Biotherapeutics
IOVA
$2.04B
| $118K | ﹤0.01% |
+10,744
| New | +$141K |
|
|
FREE
3011
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $118K | ﹤0.01% |
19,370
| – | – |
|
|
ZYXI
3012
DELISTED
Zynex
ZYXI
| $117K | ﹤0.01% |
14,545
-2,047
| -12% | -$14.5K |
|
|
NPKI
3013
NPK International
NPKI
$1.02B
| $117K | ﹤0.01% |
37,884
| – | – |
|
|
CELL
3014
DELISTED
PhenomeX Inc. Common Stock
CELL
| $116K | ﹤0.01% |
23,572
+5,907
| +33% | +$30.9K |
|
3015
Ouster
OUST
$2.11B
| $115K | ﹤0.01% |
7,059
+363
| +5% | +$10.2K |
|
|
CMLS
3016
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $114K | ﹤0.01% |
14,767
-202
| -1% | -$2.37K |
|
3017
Alto Ingredients
ALTO
$338M
| $111K | ﹤0.01% |
30,058
+3,034
| +11% | +$15.9K |
|
3018
MINISO
MNSO
$3.88B
| $111K | ﹤0.01% |
14,132
+286
| +2% | +$1.95K |
|
|
OPTN
3019
DELISTED
OptiNose
OPTN
| $111K | ﹤0.01% |
2,044
-445
| -18% | -$16.4K |
|
|
BTRS
3020
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $110K | ﹤0.01% |
22,011
-19,849
| -47% | -$114K |
|
3021
Oportun Financial
OPRT
$262M
| $109K | ﹤0.01% |
12,908
-250
| -2% | -$2.88K |
|
3022
Holley
HLLY
$335M
| $108K | ﹤0.01% |
+10,074
| New | +$110K |
|
3023
Local Bounti
LOCL
$23M
| $108K | ﹤0.01% |
2,573
-201
| -7% | -$14.8K |
|
|
VISN
3024
Vistance Networks Inc
VISN
$2.61B
| $107K | ﹤0.01% |
17,545
-137,829
| -89% | -$963K |
|
3025
CALL
NIO
NIO
$11.9B
| $107K | ﹤0.01% |
+4,900
| New | +$89.9K |
|
Similar funds
HSBC Holdings's Q2 2022 Portfolio in Review
As of Q2 2022, HSBC Holdings held 3,576 positions worth $71.6B, down 13% from $82.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
HSBC Holdings deployed $3.66B of net new capital in Q2 2022, opening 329 new positions and adding to 1,351 existing holdings. Its largest new stake was Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock: 1,690,461 shares worth $16.5M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $604M trimmed.
- HSBC Holdings's largest Q2 2022 buy was Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock: 1,690,461 shares worth $16.5M.
- HSBC Holdings added most to Amazon in Q2 2022, an estimated $526M increase.
- HSBC Holdings's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $604M.
- HSBC Holdings fully exited Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A in Q2 2022, selling an estimated $200M.
- HSBC Holdings's ten largest holdings make up 22% of its $71.6B portfolio in Q2 2022.
- HSBC Holdings opened 329 new positions and closed 362 in Q2 2022.
- HSBC Holdings's portfolio value fell 13% quarter-over-quarter to $71.6B.
Based on HSBC Holdings's 13F filing for Q2 2022, filed 11 Aug 2022.